Entheon Biomedical Corp.

CNSX:ENBI Stock Report

Market Cap: CA$1.2m

Entheon Biomedical Balance Sheet Health

Financial Health criteria checks 4/6

Entheon Biomedical has a total shareholder equity of CA$229.1K and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$249.3K and CA$20.2K respectively.

Key information

0%

Debt to equity ratio

CA$0

Debt

Interest coverage ration/a
CashCA$228.60k
EquityCA$229.13k
Total liabilitiesCA$20.19k
Total assetsCA$249.32k

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: ENBI's short term assets (CA$244.3K) exceed its short term liabilities (CA$20.2K).

Long Term Liabilities: ENBI has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: ENBI is debt free.

Reducing Debt: ENBI had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ENBI has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ENBI has less than a year of cash runway if free cash flow continues to grow at historical rates of 41.5% each year.


Discover healthy companies